Datroway approved in the US for patients with previously treated metastatic HR-positive breast cancer
Datroway is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030
Datroway is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030
Subscribe To Our Newsletter & Stay Updated